🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 2 Randomized Study to Evaluate the Effects of triamcinolone acetoni...
Status
Recruiting
Location
University of Kansas Medical Center
Start Date
2024-08-16
Trial ID
NCT06478186
The purpose of this study was to evaluate the safety, pharmacokinetics and ...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01487200
Treatments Being Tested
This is an open-label study to compare systemic exposure to triamcinolone a...
Status
Completed
Location
TriWest Research Associates, LLC
Start Date
2017-12-18
Trial ID
NCT03382262
Treatments Being Tested
The purpose of this study was to evaluate the safety, efficacy and pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01487161
This is a randomized, open-label, parallel group study to compare systemic ...
Status
Completed
Location
LA Biomed at Harbor-UCLA Medical Center
Start Date
2017-12-06
Trial ID
NCT03378076
Treatments Being Tested
This study was a double-blind, randomized, parallel group, proof of concept...
Status
Terminated
Location
San Antonio Military Medical Center
Start Date
2015-02
Trial ID
NCT02468583
Treatments Being Tested
The purpose of this study was to assess the safety and efficacy of FX006 fo...
Status
Completed
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02357459
The objectives of this study were to characterize the local extent and dura...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02637323
Treatments Being Tested
The purpose of this study was to compare the effects of FX006 and Triamcino...
Status
Completed
Location
Multiple Locations
Start Date
2016-04
Trial ID
NCT02762370
Treatments Being Tested
The purpose of this study was to characterize the local duration of exposur...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT02003365
Treatments Being Tested